Recent Miscellaneous Articles
Guest post contributor Brad Power is an expert in the field of business process innovation. He is applying his own cancer experience to help usher in truly personalized cancer care and the engagement of patient ‘scientists’.
Poet Matt Mumber, an integrative radiation oncologist serving a rural Georgia community, is among a long list of physician poets—past and present—that include Oliver Wendall Holmes, John Keats, and Rafael Campo. Here are five poems from Matt Mumber’s latest book, The Attending.
I’ve learned a few things over the 30 years since being diagnosed with cancer. These personal lessons, combined with what I’ve gleaned from 19 years as a cancer coach, greatly shapes my ever-growing understanding of cancer—and its prevention and control.
The business of cancer care is complex, and not always, shall we say, fair and transparent to patients … especially when it comes to treatment costs. This opaqueness is especially problematical when it comes to cancer therapies such as chemotherapy that are infused intravenously in a hospital or clinic. The decision-making process, through which standard of care drug(s) are recommended and ultimately prescribed, can cross a line that favors profit over true patient value.
Sometimes it’s necessary to part ways with your oncologist. There are times when circumstances demand finding a better fit for your unique situation and priorities.
In cancer parlance, I have been NED—no evidence of disease—for a decade. This month marks 10 years since I cleared my bone marrow of leukemic cells, and without conventional therapy. What does it mean?
For those of us living with cancer, this is what being proactive looks like right now in 4 steps. Because this is no time to lower your defenses.
We’ve turned the calendar revealing a new year. And with that a renewed opportunity—if you are so inclined, motivated, and able—to improve your personal health: self-care and medical management, including lifestyle choices and staying on top of the scientific advancements specific to the malignant challenge you may be hosting.
Despite the remarkable progress in drug development across several populations of cancer, troubling facts have recently emerged about several expensive FDA-approved anticancer drugs.
Over the years I’ve coached many people who were determined to forego conventional cancer care—going against their oncologists’ recommendations, and often countering their partners’ and families’ opinions, too.